Ng I S, Ong J B, Tan C L, Law H Y
Department of Paediatrics, Singapore General Hospital, Singapore.
Ann Acad Med Singap. 1996 Nov;25(6):779-82.
beta-thalassaemia is one of the commonest autosomal recessive genetic diseases in the Singapore population. In the homozygous form, it results in a severe anaemia, requiring monthly transfusion for survival. Because of the less than satisfactory treatment available for the condition, prenatal diagnosis has always been an option for couples at-risk. The available method was globin chain analysis of foetal blood, obtained at 18 to 20 weeks of gestation. Affected pregnancies would then be diagnosed and require termination in the mid to late trimester. A relatively newer technique, chorionic villus sampling (CVS), allows foetal material to be obtained in the first trimester. However, analysis of the foetal tissue requires direct gene studies to be performed. The aim of this study was to evaluate the feasibility of this analysis in couples at-risk for beta-thalassaemia in Singapore. Sixteen couples who were at-risk for a child with beta-thalassaemia major were offered prenatal diagnosis. All of them opted for CVS as compared to foetal blood sampling. The mutations in the beta-globin gene in these couples at-risk were identified. Direct gene analysis was then performed on the foetal sample, using a variety of molecular techniques. These included reverse dot-blot hybridisation, allele-specific oligonucleotide hybridisation, restriction enzyme digests and direct analysis of amplified products. DNA profiling was done for each case to exclude definitively the possibility of maternal tissue contaminating the foetal sample. The results in all these cases were unequivocal. The procedure of CVS itself was uneventful in these 16 couples. Procedural-associated foetal loss was nil. Prenatal diagnosis in the first trimester allows early termination of an affected pregnancy with significantly less maternal morbidity and prenatal anxiety. It also results in greater patient acceptability of the procedure and plays a key role in the prevention of this devastating genetic disease.
β地中海贫血是新加坡人群中最常见的常染色体隐性遗传病之一。纯合子形式会导致严重贫血,患者需每月输血以维持生命。由于针对该病症的现有治疗方法不尽人意,对于有风险的夫妇而言,产前诊断一直是一种选择。可用的方法是对妊娠18至20周时获取的胎儿血液进行珠蛋白链分析。确诊为患病的妊娠随后将在孕中期至晚期终止。一种相对较新的技术,即绒毛取样(CVS),可在孕早期获取胎儿组织。然而,对胎儿组织的分析需要进行直接基因研究。本研究的目的是评估在新加坡有β地中海贫血风险的夫妇中进行这种分析的可行性。为16对有患重型β地中海贫血患儿风险的夫妇提供了产前诊断。与胎儿血液取样相比,他们都选择了绒毛取样。确定了这些有风险夫妇β珠蛋白基因中的突变。然后使用多种分子技术对胎儿样本进行直接基因分析。这些技术包括反向点杂交、等位基因特异性寡核苷酸杂交、限制性酶切消化以及对扩增产物的直接分析。对每个病例进行DNA谱分析,以明确排除母体组织污染胎儿样本的可能性。所有这些病例的结果都很明确。在这16对夫妇中,绒毛取样过程本身顺利。与操作相关的胎儿丢失为零。孕早期进行产前诊断可使受影响的妊娠早期终止,产妇发病率和产前焦虑明显降低。这也提高了患者对该操作的接受度,并在预防这种毁灭性遗传病方面发挥关键作用。